MM
BEAM icon

MWG Management’s Beam Therapeutics BEAM Stock Holding History

MWG Management’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$55M Hold
2,266,934
– – 67.66% 1
2025
Q2 		$38.6M Hold
2,266,934
– – 74.3% 1
2025
Q1 		$44.3M Hold
2,266,934
– – 75.44% 1
2024
Q4 		$56.2M Hold
2,266,934
– – 75.61% 1
2024
Q3 		$55.5M Hold
2,266,934
– – 61.51% 1
2024
Q2 		$53.1M Sell
2,266,934
-80,000
-3% -$1.96M 58.01% 1
2024
Q1 		$77.5M Hold
2,346,934
– – 57.42% 1
2023
Q4 		$63.9M Hold
2,346,934
– – 53.74% 1
2023
Q3 		$56.4M Hold
2,346,934
– – 54.7% 1
2023
Q2 		$74.9M Hold
2,346,934
– – 45.33% 1
2023
Q1 		$71.9M Hold
2,346,934
– – 50.6% 1
2022
Q4 		$91.8M Hold
2,346,934
– – 46.86% 1
2022
Q3 		$112M Hold
2,346,934
– – 43.07% 2
2022
Q2 		$90.8M Hold
2,346,934
– – 40.87% 2
2022
Q1 		$134M Hold
2,346,934
– – 56.91% 1
2021
Q4 		$187M Sell
2,346,934
-15,701
-0.7% -$1.34M 54.51% 1
2021
Q3 		$206M Hold
2,362,635
– – 24.93% 2
2021
Q2 		$304M Hold
2,362,635
– – 29.88% 3
2021
Q1 		$189M Buy
2,362,635
+2,360,810
+129,359% +$225M 91.9% 1
2020
Q4 		$149K Buy
+1,825
New +$89.7K 94.48% 1

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

MWG Management's BEAM Position: Q3 2025 in Review

MWG Management held its Beam Therapeutics (BEAM) position steady in Q3 2025 at 2,266,934 shares worth $55M. The position accounts for 67.66% of the portfolio, ranked #1.

MWG Management first reported a position in BEAM in Q4 2020 and has held it in 20 quarters since. The position peaked at $304M in Q2 2021. 219 funds tracked by Wall St. Rank hold BEAM as of Q3 2025.

  • MWG Management held 2,266,934 shares of Beam Therapeutics worth $55M as of Q3 2025.
  • MWG Management left its Beam Therapeutics share count unchanged in Q3 2025.
  • Beam Therapeutics made up 67.66% of MWG Management's portfolio in Q3 2025, its #1 holding.
  • MWG Management first reported a position in Beam Therapeutics in Q4 2020 and has held it in 20 quarters since.
  • MWG Management's Beam Therapeutics position peaked at $304M in Q2 2021.
  • 219 funds tracked by Wall St. Rank held Beam Therapeutics as of Q3 2025.

Based on MWG Management's 13F filing for Q3 2025, filed 12 Nov 2025.